Cargando…
Improved Survival With Integration of Chinese Herbal Medicine Therapy in Patients With Acute Myeloid Leukemia: A Nationwide Population-Based Cohort Study
Purpose. Acute myeloid leukemia (AML) is the most deadly subtype of leukemia, and many patients with this disease seek other complementary therapies, one of which is Chinese medicine. We set out to provide reliable data regarding the benefit of Chinese herbal medicine (CHM) for AML patients, using m...
Autores principales: | Fleischer, Tom, Chang, Tung-Ti, Chiang, Jen-Huai, Sun, Mao-Feng, Yen, Hung-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739127/ https://www.ncbi.nlm.nih.gov/pubmed/27531548 http://dx.doi.org/10.1177/1534735416664171 |
Ejemplares similares
-
Adjunctive Chinese Herbal Medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population‐based cohort study
por: Fleischer, Tom, et al.
Publicado: (2016) -
Integration of Chinese Herbal Medicine Therapy Improves Survival of Patients With Chronic Lymphocytic Leukemia: A Nationwide Population-Based Cohort Study
por: Fleischer, Tom, et al.
Publicado: (2016) -
Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study
por: Kuo, Yi-Ting, et al.
Publicado: (2017) -
A Controlled Trial of Sheng-Yu-Tang for Post–Hematopoietic Stem Cell
Transplantation Leukemia Patients: A Proposed Protocol and Insights From a
Preliminary Pilot Study
por: Fleischer, Tom, et al.
Publicado: (2018) -
Chinese Herbal Medicine as an Adjunctive Therapy Improves the Survival Rate of Patients with Ischemic Heart Disease: A Nationwide Population-Based Cohort Study
por: Hung, I.-Ling, et al.
Publicado: (2022)